CA1228819A - Methode et composes pour combattre les tumeurs - Google Patents

Methode et composes pour combattre les tumeurs

Info

Publication number
CA1228819A
CA1228819A CA000436310A CA436310A CA1228819A CA 1228819 A CA1228819 A CA 1228819A CA 000436310 A CA000436310 A CA 000436310A CA 436310 A CA436310 A CA 436310A CA 1228819 A CA1228819 A CA 1228819A
Authority
CA
Canada
Prior art keywords
carnitine
composition
tumor
fatty acid
chain fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000436310A
Other languages
English (en)
Inventor
Austin L. Shug
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1228819A publication Critical patent/CA1228819A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000436310A 1982-09-13 1983-09-08 Methode et composes pour combattre les tumeurs Expired CA1228819A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41717982A 1982-09-13 1982-09-13
US417,179 1982-09-13

Publications (1)

Publication Number Publication Date
CA1228819A true CA1228819A (fr) 1987-11-03

Family

ID=23652899

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000436310A Expired CA1228819A (fr) 1982-09-13 1983-09-08 Methode et composes pour combattre les tumeurs

Country Status (4)

Country Link
JP (1) JPS59130213A (fr)
BE (1) BE897738A (fr)
CA (1) CA1228819A (fr)
IT (1) IT1169460B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8388949B2 (en) 2003-12-24 2013-03-05 N.V. Nutricia Compositions comprising pantothenic acid and their use for stimulating appetite

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720860B2 (ja) * 1984-02-24 1995-03-08 理化学研究所 制癌剤
US6316652B1 (en) * 1995-06-06 2001-11-13 Kosta Steliou Drug mitochondrial targeting agents
EP1100589B1 (fr) * 1998-07-30 2005-01-19 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Utilisation de propionyle l-carnitine et d'acetyl l-carnitine dans la preparation de medicaments a action anticancereuse

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8388949B2 (en) 2003-12-24 2013-03-05 N.V. Nutricia Compositions comprising pantothenic acid and their use for stimulating appetite

Also Published As

Publication number Publication date
IT8322785A0 (it) 1983-09-06
BE897738A (fr) 1984-01-02
IT8322785A1 (it) 1985-03-06
IT1169460B (it) 1987-05-27
JPS59130213A (ja) 1984-07-26

Similar Documents

Publication Publication Date Title
Khan et al. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature
Fischer et al. Growth of animal tissue cells in artificial media.
DK2611439T3 (en) PARENTERAL APPLICATION OF FISH OIL / DHA + EPA BEFORE OR AT THE BEGINNING OF CHEMOTHERAPY
RU2013110491A (ru) Использование кислой лизосомной липазы для лечения дефицита кислой лизосомной липазы у больных
Dippenaar, N.,* Booyens, J.,* Fabbri, D.,* Engelbrecht, P.* & Katzeff The reversibility of cancer: evidence that malignancy in human hepatoma cells is gamma-linolenic acid deficiency-dependent
CA1228819A (fr) Methode et composes pour combattre les tumeurs
KR100239946B1 (ko) 자라와 거북의 조성물
US4898886A (en) Urea against adenocarcinoma
US5744498A (en) Inhibiting growth and spread of malignancy and retarding DNA breaks
JP3319597B2 (ja) 細胞培養及び治療に有用なβ―アレチン
Chun et al. Combination immunotherapy of cancer in a mouse model: synergism between tumor necrosis factor and other defense systems
JP7186253B2 (ja) アミガサタケ属（Ｍｏｒｃｈｅｌｌａ）活性物質の使用
AU2004244755B2 (en) Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds
US6046241A (en) β-alethine as anti-tumor agent
EP0280593A2 (fr) Composition à base d'acide aminé et de vitamines utilisable en thérapeutique cancérologique
JPS62263127A (ja) 自己由来のｌａｋ細胞、インタ−ロイキン−２、及びオルニチンデカルボキシラ−ゼ阻害剤による腫瘍の処置
Ohya Studies on the effect of the tissue substance" cornin" on transplantable malignant tumors in mice
Jurin et al. Porcine splenic peptides (Polyerga) decrease the number of experimental lung metastases in mice
Holcenberg Enhanced Effect of an L-Glutamine Antagonist, L-(aS, 5S)-α-Amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-Glutaminase-L-Asparaginase ¹
Umezawa The Leeuwenhoek Lecture, 1982-Studies of microbial products in rising to the challenge of curing cancer
US20230144882A1 (en) Use of adenosine deaminase and adenosinedeaminase modifier in preparation of medicamentfor wound repair in patient with diabetes
JPS62123128A (ja) ヨウ素含有淡水クロレラおよびそれを主成分とする抗癌剤
CN113440601B (zh) Nk细胞和tfpi联用在防治鼻咽癌中的应用
Berk, Lionel, Bauer, John L. & Castle Folic acid: A report of 12 patients treated with synthetic pteroylglutamic acid: With comments on the pertinent literature
US3496267A (en) Pharmaceutical compositions containing lyophilized cardiac mitochondria

Legal Events

Date Code Title Description
MKEX Expiry